Clinical Study

Levels of Salivary IFN-gamma, TNF-Alfa, and TNF Receptor-2 As Prognostic Markers in (Erosive) Oral Lichen Planus

Table 2

The change of IFN-γ, TNF-α, and TNFR-2 salivary levels in ELP patients treated with prednisone and control subjects.

IFN-γTNF-αTNFR-2

ELP before treatmentMean ± SD23.953 ± 5.3344.485 ± 16.81350.4 ± 330.89
Median18.3055.601029

ELP after treatmentMean ± SD17.237 ± 5.6821.33 ± 17.2114.0 ± 11.39
Median15.3954.3031

ControlMean ± SD6.41 ± 2.531.405 ± 0.2545 ± 13.82
Median6.090.9043

Before versus after 𝑃 value 𝑃 . 0 0 1 𝑃 . 0 5 𝑃 . 0 1

Before versus control 𝑃 value 𝑃 . 0 0 0 1 𝑃 . 0 0 0 1 𝑃 . 0 1